Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care 2016;39:1108-1114

Jens Jordan, Ali El-Armouche, Markolf Hanefeld, Stefan R. Bornstein, Andreas L. Birkenfeld
Dec 1, 2016; 39:224-225
e-Letters: Comments and Responses
Diabetes Care: Most-Read Full-Text Articles





  • Twitter
  • del.icio.us
  • Digg
  • Facebook
  • Technorati
  • Reddit
  • Yahoo Buzz
  • StumbleUpon

Leave a Reply

Your email address will not be published. Required fields are marked *